Anzeige
Mehr »
Login
Freitag, 21.02.2025 Börsentäglich über 12.000 News von 688 internationalen Medien
Neues Allzeithoch: Sensationelle Goldfunde! - könnte das der nächste Multi-Bagger sein?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40E1B | ISIN: US47010C8055 | Ticker-Symbol: 1JA
NASDAQ
20.02.25
22:00 Uhr
0,881 US-Dollar
0,000
0,00 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
JAGUAR HEALTH INC Chart 1 Jahr
5-Tage-Chart
JAGUAR HEALTH INC 5-Tage-Chart

Aktuelle News zur JAGUAR HEALTH Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
DoJaguar Health, Inc. - 8-K, Current Report1
MiJaguar Health, Inc.: Jaguar Receives Regulatory Clearance in Germany and Italy for Crofelemer for Rare Disease Study - Short Bowel Syndrome with Intestinal Failure182This study, initiated yesterday, is one of five clinical efforts - three proof-of-concept (POC) investigator-initiated trials (IIT) and two Phase 2 studies - of crofelemer for the rare disease indications...
► Artikel lesen
DiJaguar Health advances cholera treatment, eyes FDA voucher7
DiJaguar Health, Inc.: Jaguar Health Extends Collaboration for Possible Tropical Disease Priority Review Voucher and Cholera Indication for NP-300167Priority Review Vouchers (PRVs) are transferable and, in past transactions by other companies, have sold for prices up to $350 million1.3 to 4 million cholera cases and 21,000 to 143,000 cholera-related...
► Artikel lesen
13.02.Jaguar Health, Inc.: Jaguar Health Presenting February 18 at Emerging Growth Conference to Provide Updates on Near-Term Catalysts270SAN FRANCISCO, CA / ACCESS Newswire / February 13, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Lisa Conte, the company's founder, president and CEO, will present virtually on Tuesday...
► Artikel lesen
JAGUAR HEALTH Aktie jetzt für 0€ handeln
06.02.Jaguar Health, Inc.: Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, to Present February 10th at BIO CEO & Investor Conference303Magdalena aiming to submit Investigational New Drug (IND) application in 2025 to the FDA for a next-generation psychoactive prescription drug candidate for potential mental health indications such as...
► Artikel lesen
03.02.Jaguar Health, Inc.: Jaguar Health Announces First Patient Dosed in Short Bowel Syndrome with Intestinal Failure in Investigator-Initiated Trial of Crofelemer; Proof-of-Concept Data Potentially Available H1 2025228Trial taking place at Sheikh Khalifa Medical City, a flagship United Arab Emirates hospital and largest teaching medical center in Abu DhabiCrofelemer, Jaguar's novel plant-based prescription drug,...
► Artikel lesen
29.01.Jaguar Health, Inc.: Jaguar Health Supports Evaluation of FDA-Approved Crofelemer to Address GI Side Effects of GLP-1 and Other Weight Loss Therapies: Files Patent Application with USPTO270Gastrointestinal disorders are the most frequently reported adverse effects during clinical trials of GLP-1 agonists; GI adverse events usually develop in 40-70% of treated patients, and have been reported...
► Artikel lesen
22.01.Jaguar Health, Inc.: Jaguar Health Announces First Patient Dosed in Investigator-Initiated Trial Evaluating Crofelemer for the Rare Disease Indication of Microvillus Inclusion Disease , with Proof-of-Concept Data Potentially Available H1 2025231Trial taking place at Sheikh Khalifa Medical City, a flagship tertiary hospital in the United Arab EmiratesPOC data generated from this study could potentially lead to reimbursed early patient access...
► Artikel lesen
15.01.Jaguar Health-Aktie erreicht 52-Wochen-Tief bei 0,84 US-Dollar12
10.01.Jaguar Health, Inc.: Jaguar Health Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635426SAN FRANCISCO, CA / ACCESSWIRE / January 10, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced that, effective January 8, 2025, the Company granted 15,000 restricted...
► Artikel lesen
08.01.Jaguar Health, Inc.: Jaguar Health Presenting January 13 at Lytham 2025 Investor Healthcare Summit & January 14 at Biotech Showcase321SAN FRANCISCO, CA / ACCESSWIRE / January 8, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that Lisa Conte, the company's founder, president and CEO, will participate in a virtual fireside...
► Artikel lesen
07.01.Jaguar Health, Inc.: Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, to Present January 12 at the Annual Neuroscience Innovation Forum356Magdalena aiming to submit Investigational New Drug (IND) application in early 2025 to the FDA for a next-generation psychoactive prescription drug candidate for potential mental health indications...
► Artikel lesen
19.12.24Jaguar Health, Inc.: Jaguar Health Announces Import of Coca Leaf From Peru by Joint Venture Magdalena Biosciences for Research in Treating Mental Health Indications421Magdalena to explore coca leaf's possible therapeutic benefit for treatment of potentially ADHD or other neuropsychiatric indicationsThe import was conducted in collaboration with the government of...
► Artikel lesen
18.12.24Jaguar Health, Inc.: Phase 2 Study Initiated to Evaluate Jaguar Health's Crofelemer for Microvillus Inclusion Disease , an Ultrarare Congenital Diarrheal Disorder467The study is one of five clinical efforts - three proof-of-concept investigator-initiated trials (IIT) and two Phase 2 studies - of crofelemer for the rare disease indications of MVID and/or short bowel...
► Artikel lesen
17.12.24FDA approves orphan-drug designation for Jaguar Health's cholera drug, Crofelemer9
17.12.24Jaguar Health, Inc.: FDA Approves Orphan-Drug Designation for Jaguar Health's Crofelemer for Treatment of Diarrhea in Cholera500World Health Organization (WHO) has classified the global resurgence of cholera at the highest internal level for emergencies; 1.3 to 4 million cholera cases and 21,000 to 143,000 cholera-related deaths...
► Artikel lesen
16.12.24Jaguar Health-Aktie stürzt auf 52-Wochen-Tief von 0,87 US-Dollar6
13.12.24Jaguar Health, Inc.: Ladenburg Thalmann to Host Scientific Showcase December 18, 2024 About Rare Disease Clinical Development Efforts for Jaguar Health's Crofelemer385Crofelemer is the subject of five clinical efforts - three proof-of-concept investigator-initiated trials (IIT) and two Phase 2 studies - for the rare disease indications of microvillus inclusion disease...
► Artikel lesen
12.12.24Jaguar Health, Inc.: Significant Positive Results with Jaguar Health's Crofelemer for Cancer Therapy-Related Diarrhea in Breast Cancer Patients Presented at San Antonio Breast Cancer Symposium331Adult patients with breast cancer are a prespecified subgroup of the recently conducted phase 3 OnTarget trial evaluating crofelemer for prophylaxis of CTDThe majority of patients in the OnTarget placebo...
► Artikel lesen
Seite:  Weiter >>
93 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,2